SNCA and Parkinson disease: Given the growing body of experimental evidence concerning visual dysfunction and morphological impairments in the retina of PD patients and MPTP-treated animals [27-30], including that from our group [20], we set out to analyze α-synuclein expression at the mRNA and protein levels and to characterize its distribution pattern in the distinct retinal layers and cell types.